Chromocell Therapeutics Corporation (CHRO)
NYSEAMERICAN: CHRO · Real-Time Price · USD
0.619
+0.078 (14.42%)
At close: Nov 20, 2024, 4:00 PM
0.632
+0.013 (2.04%)
After-hours: Nov 20, 2024, 7:47 PM EST
Chromocell Therapeutics Market Cap
Chromocell Therapeutics has a market cap or net worth of $3.73 million as of November 21, 2024.
Market Cap
3.73M
Enterprise Value
4.77M
1-Year Change
n/a
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since the IPO on February 16, 2024, Chromocell Therapeutics's market cap has decreased from $33.50M to $3.73M, a decrease of -88.86%. That is a compound annual growth rate of -94.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 3.73M | -88.86% |
| Feb 16, 2024 | 33.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pasithea Therapeutics | 4.05M |
| Aptevo Therapeutics | 3.99M |
| XORTX Therapeutics | 3.99M |
| Hepion Pharmaceuticals | 3.99M |
| Artelo Biosciences | 3.94M |
| Genetic Technologies | 3.78M |
| Biofrontera | 3.73M |
| Lixte Biotechnology Holdings | 3.58M |